Trial intelligence / Profile preview

Tadalafil effects on urethral and anal function in healthy females

NCT05095077Phase 1Completed

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Aug 2021
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in urinary incontinence (UI) and fecal incontinence (FI) comparing Tadalafil First with Placebo First (2 arms). Primary endpoint: Placebo-corrected change in opening urethral pressure. Started Aug 2021; status: completed.

02

Drugs

tadalafil
03

Conditions

urinary incontinence (UI)fecal incontinence (FI)

Beyond the preview

Go deeper on NCT05095077.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05095077.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call